Myriad Genetics, Inc. · NASDAQ:MYGN
Camber Capital Management LP's stake in Myriad Genetics, Inc. fell to 3.41% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Camber Capital Management LP's stake in Myriad Genetics, Inc. fell to 3.41%, 3,100,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 3.41%
- Shares
- 3,100,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Camber Capital Management LP | 3.41% | 3,100,000 |
| Stephen DuBois | 3.41% | 3,100,000 |
Source
Related
- Myriad Genetics, Inc.
- Camber Capital Management LP
- Myriad Genetics, Inc. shareholders
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026